| Thomas Lee, MD | |
|
7420 Market St, Wilmington, NC 28411-9453 | |
| (910) 662-6200 | |
| (910) 686-1606 |
| Full Name | Thomas Lee |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 7420 Market St, Wilmington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497774004 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 9900582 (North Carolina) | Secondary |
| 207R00000X | Internal Medicine | 9900582 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Well Care Home Health | Wilmington, NC | Home health agency |
| Lower Cape Fear Hospice Inc | Wilmington, NC | Hospice |
| New Hanover Regional Medical Center | Wilmington, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Health Medical Group Coastal Region Llc | 2860809936 | 412 |
News Archive
A Data and Safety Monitoring Committee (DSMC) has determined that patients in a phase III clinical trial given atrasentan in addition to a standard chemotherapy regimen for advanced prostate cancer did not have longer survival or longer progression-free survival than patients on the same chemotherapy regimen who got a placebo rather than atrasentan.
Ranolazine is an effective anti-anginal therapy in patients with refractory angina; however, at one year only 59 percent of patients remained on the drug, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions in New Orleans, April 1-3.
People living with Hepatitis C are highly critical of the treatment they have received from health professionals, particularly doctors, according to a new study by a University of Auckland sociology researcher.
Celera Corporation (NASDAQ:CRA) and Medco Health Solutions, Inc. (NYSE:MHS), today announced that they have entered into a research collaboration to evaluate whether testing for a gene variant called KIF6 increases patient adherence with statin therapy. Current studies have suggested that only about 50 to 60 percent of the patients who receive a prescription for a lipid-lowering drug are taking the medication after six months.
› Verified 8 days ago
| Entity Name | Novant Health Medical Group Coastal Region Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649865791 PECOS PAC ID: 2860809936 Enrollment ID: O20210408000285 |
News Archive
A Data and Safety Monitoring Committee (DSMC) has determined that patients in a phase III clinical trial given atrasentan in addition to a standard chemotherapy regimen for advanced prostate cancer did not have longer survival or longer progression-free survival than patients on the same chemotherapy regimen who got a placebo rather than atrasentan.
Ranolazine is an effective anti-anginal therapy in patients with refractory angina; however, at one year only 59 percent of patients remained on the drug, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions in New Orleans, April 1-3.
People living with Hepatitis C are highly critical of the treatment they have received from health professionals, particularly doctors, according to a new study by a University of Auckland sociology researcher.
Celera Corporation (NASDAQ:CRA) and Medco Health Solutions, Inc. (NYSE:MHS), today announced that they have entered into a research collaboration to evaluate whether testing for a gene variant called KIF6 increases patient adherence with statin therapy. Current studies have suggested that only about 50 to 60 percent of the patients who receive a prescription for a lipid-lowering drug are taking the medication after six months.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Lee, MD Po Box 936857, Atlanta, GA 31193-6857 Ph: () - | Thomas Lee, MD 7420 Market St, Wilmington, NC 28411-9453 Ph: (910) 662-6200 |
News Archive
A Data and Safety Monitoring Committee (DSMC) has determined that patients in a phase III clinical trial given atrasentan in addition to a standard chemotherapy regimen for advanced prostate cancer did not have longer survival or longer progression-free survival than patients on the same chemotherapy regimen who got a placebo rather than atrasentan.
Ranolazine is an effective anti-anginal therapy in patients with refractory angina; however, at one year only 59 percent of patients remained on the drug, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions in New Orleans, April 1-3.
People living with Hepatitis C are highly critical of the treatment they have received from health professionals, particularly doctors, according to a new study by a University of Auckland sociology researcher.
Celera Corporation (NASDAQ:CRA) and Medco Health Solutions, Inc. (NYSE:MHS), today announced that they have entered into a research collaboration to evaluate whether testing for a gene variant called KIF6 increases patient adherence with statin therapy. Current studies have suggested that only about 50 to 60 percent of the patients who receive a prescription for a lipid-lowering drug are taking the medication after six months.
› Verified 8 days ago
Dr. James Carden Mccabe, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1302 Medical Center Dr, Wilmington, NC 28401 Phone: 910-343-9800 Fax: 910-343-9800 | |
Michael Mundy Ward, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2215 Canterwood Dr, Wilmington, NC 28401 Phone: 910-762-4600 Fax: 910-762-9483 | |
Latessa Spiers, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1960 S 16th St, Wilmington, NC 28401 Phone: 910-343-9991 | |
Dr. Kavita S Persaud, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5919 Oleander Dr Ste 109, Wilmington, NC 28403 Phone: 910-799-5508 Fax: 910-202-0654 | |
Dr. Regina Marie Jensen, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4536 Technology Dr, Ste 3, Wilmington, NC 28405 Phone: 910-343-8411 Fax: 910-343-8414 | |
Mary Kathryn Rudyk, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1709 S 16th St Ste A, Wilmington, NC 28401 Phone: 910-452-8633 Fax: 910-452-8569 | |
Gregory Roberts, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1202 Medical Center Dr, Wilmington, NC 28401 Phone: 910-341-3300 Fax: 910-341-7946 |